Sun Pharmaceutical Industries Limited
₹1,812.70+₹51.70 (+2.94%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
NSE · MADHAVBAUG.NS · INR
Stock price
Quote as of Oct 30, 2026, 07:16 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Vaidya Sane Ayurved Laboratories Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Vaidya Sane Ayurved Laboratories Ltd., operating commercially as Madhavbaug, is an Indian specialist healthcare provider focused on the non-invasive treatment and management of lifestyle-related chronic diseases, primarily cardiac ailments, diabetes, hypertension, obesity, and knee pain. The company integrates traditional Ayurvedic practices with modern medical diagnostics. It operates a network of multidisciplinary clinics and two cardiac hospitals across various Indian states, offering clinical consultations, specialized Ayurvedic procedures, and chronic disease reversal programs. Additionally, the company is involved in the research, development, and sale of proprietary Ayurvedic medicines, health supplements, and wellness products, which are distributed through its clinics, e-pharmacy platform, and online portals. Its target market includes individuals in India suffering from these chronic conditions, leveraging an integrated approach within the chronic care ecosystem.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
₹1,812.70+₹51.70 (+2.94%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
₹9,808.50+₹144.50 (+1.5%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.35% below the high.
₹4,640.10+₹60.10 (+1.31%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 11.68% below the high.
₹2,370.40+₹126.40 (+5.63%)
Laurus Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 0.48% below the high.
₹1,241.40+₹57.00 (+4.81%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 0.59% below the high.
₹8,312.00+₹112.00 (+1.37%)
Apollo Hospitals Enterprise Limited’s quoted price sits in the upper half of its reported 52-week range, 8.36% below the high.
₹682.20+₹0.45 (+0.07%)
Lenskart Solutions Limited’s quoted price sits in the upper half of its reported 52-week range, 5.9% below the high.
₹1,359.00+₹14.00 (+1.04%)
Dr. Reddy's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 4.05% below the high.